Home Radioiodination and biological evaluation of landiolol as a tracer for myocardial perfusion imaging: preclinical evaluation and diagnostic nuclear imaging
Article
Licensed
Unlicensed Requires Authentication

Radioiodination and biological evaluation of landiolol as a tracer for myocardial perfusion imaging: preclinical evaluation and diagnostic nuclear imaging

  • M. H. Sanad EMAIL logo , A. B. Farag and M. A. Motaleb
Published/Copyright: September 1, 2018

Abstract

The present work has assessed the ability and competency of radioiodinated landiolol that is considered a potential cardio selective imaging agent. Landiolol was radiosynthesized with [131I] using chloramine-T (Ch-T) as an oxidizing agent. To give high radiochemical yield of the [131I]landiolol reaching values of 98% with high stability up to 48 h. The labeled compound was separated and purified using thin layer chromatography (TLC), paper electrophoresis and high performance liquid chromatography (HPLC). Biodistribution studies indicated that [131I]landiolol gave high heart uptake ratio of [45.0±0.19% ID/g at 2 min post injection (p.i.)]. Therefore, [131I]landiolol could be considered as a novel tracer to image heart with high heart/blood ratio within 60 min.

References

1. Iguchi, S., Iwamura, H., Nishizaki, M., Hayashi, A., Senokuchi, K., Kobayashi, K., Sakaki, K., Hachiya, K., Ichioka, Y., Kawamura, M.: Development of a highly cardioselective ultra short-acting β-blocker, ONO-1101. Chem. Pharm. Bull. 40(6), 1462 (1992).10.1248/cpb.40.1462Search in Google Scholar PubMed

2. Yamakage, M., Iwasaki, S., Jeong, S-W., Satoh, J., Namiki, A.: Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. Heart Lung 38(1), 48 (2009).10.1016/j.hrtlng.2008.01.002Search in Google Scholar PubMed

3. Kazutoshi, I., Kiyonobu, N., Sumiko, T., Tomoyuki, Y., Yoshiyuki, T., Tokuhiro, Y., Akira, A.: Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J. Anesth. 22(4), 361 (2008).10.1007/s00540-008-0640-4Search in Google Scholar PubMed

4. Shibata, S., Okamoto, Y., Endo, S., Ono, K.: Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts. J. Pharmacol. Sci. 118(2), 255 (2012).10.1254/jphs.11202FPSearch in Google Scholar PubMed

5. Kimura-Kurosawa, S., Kanaya, N., Kamada, N., Hirata, N., Nakayama, M., Namiki, A.: Cardioprotective effect and mechanism of action of landiolol on the ischemic reperfused heart. J. Anesth. 21(4), 480 (2007).10.1007/s00540-007-0558-2Search in Google Scholar PubMed

6. Saori, K., Noriaki, K., Yukitoshi, N., Masayasu, N., Satoshi, F., Akiyoshi, N.: Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts. Can. J. Anaesth. 50(5), 489 (2003).10.1007/BF03021062Search in Google Scholar PubMed

7. Honda, N., Nakade, S., Kasai, H., Hashimoto, Y., Ohno, T., Kitagawa, J., Yamauchi, A., Hasegawa, C., Kikawa, S., Kunisawa, T., Tanigawara, Y., Miyata, Y.: Population pharmacokinetics of landiolol hydrochloride in healthy subjects. Drug Metab. Pharmacokinet. 23(6), 447 (2008).10.2133/dmpk.23.447Search in Google Scholar PubMed

8. Makoto, M., Hidetoshi, F., Kyoko, M., Atsuko, W., Shinichi, K., Shin, I.: Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting β1-selective blocker, in a dose escalation regimen in healthy male volunteers. Drug Metab. Pharmacokinet. 20(5), 337 (2005).10.2133/dmpk.20.337Search in Google Scholar PubMed

9. Matsumoto, N., Aomori, T., Kanamoto, M., Usui, T., Shiga, T., Yamamoto, K., Saito, S.: Influence of hemodynamic variations on the pharmacokinetics of landiolol in patients undergoing cardiovascular surgery. Biol. Pharm. Bull. 35(10), 1655 (2012).10.1248/bpb.b110727Search in Google Scholar PubMed

10. Atarashi, H., Kuruma, A., Yashima, M., Saitoh, H., Ino, T., Endoh, Y., Hayakawa, H.: Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting β-blocker, in patients with cardiac arrhythmias. Clin. Pharmacol. Ther. 68(2), 143 (2000).10.1067/mcp.2000.108733Search in Google Scholar PubMed

11. Mori, K., Yamada, K., Fukuda, T., Mitsui, T., Kitamura, T., Yamaguchi, D., Ando, J., Wada, I., Nomura, S., Shimizu, N., Seto, Y.: Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy. Surg. Today. 44(5), 848 (2014).10.1007/s00595-013-0615-4Search in Google Scholar PubMed

12. Inoue, S., Abe, R., Kawaguchi, M., Kobayashi, H., Furuya, H.: Metoclopramide does not prolong duration of action of landiolol attenuating the hemodynamic response to induction of anesthesia and tracheal intubation. J. Anesth. 24(4), 649 (2010).10.1007/s00540-010-0945-ySearch in Google Scholar PubMed

13. Suzuki, T., Aono, M., Isaka, T., Miyake, E., Fukano, N., Saeki, S., Ogawa, S.: Effect of landiolol hydrochloride on suxamethonium-induced neuromuscular block. J. Anesth. 23(2), 188 (2009)10.1007/s00540-008-0727-ySearch in Google Scholar PubMed

14. Sezai, A., Minami, K., Nakai, T., Hata, M., Yoshitake, I., Wakui, S., Shiono, M., Hirayama, A.: Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J. Thorac. Cardiovasc Surg. 141(6), 1478 (2011).10.1016/j.jtcvs.2010.10.045Search in Google Scholar PubMed

15. Sezai, A., Nakai, T., Hata, M., Yoshitake, I., Shiono, M., Kunimoto, S., Hirayama, A.: Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. J. Thorac. Cardiovasc. Surg. 144(5), 1241 (2012).10.1016/j.jtcvs.2012.06.042Search in Google Scholar PubMed

16. Sakamoto, A., Kitakaze, M., Takamoto, S., Namiki, A., Kasanuki, H., Hosoda, S.: Landiolol, an ultra-short-acting β1-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study). Circ. J. 76(5), 1097 (2012).10.1253/circj.CJ-11-1332Search in Google Scholar PubMed

17. Fujii, M., Bessho, R., Ochi, M., Shimizu, K., Terajima, K., Takeda, S.: Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery. J. Cardiovasc. Surg. (Torino) 53(3), 369 (2012).Search in Google Scholar PubMed

18. Cleland, J. G.: Contemporary management of heart failure in clinical practice. Heart. 88(Suppl 2), ii5–8 (2002).Search in Google Scholar PubMed

19. Ohnesorge, B, Flohr, T., Becker, C., Kopp, A. F., Schoepf, U. J., Baum, U., Knez, A., Klingenbeck-Regn, K., Reiser, M. F.: Cardiac imaging by means of electrocardiographically gated multisection spiral CT: initial experience. Radiology 217(2), 564 (2000).10.1148/radiology.217.2.r00nv30564Search in Google Scholar PubMed

20. Edwards, W.D., Tajik, A.J., Seward, J.B.: Standardized nomenclature and anatomic basis for regional tomographic analysis of the heart. Mayo. Clin. Proc. 56, 479 (1981).Search in Google Scholar PubMed

21. Sanad, M. H.: Labeling and biological evaluation of 99mTc-azithromycin for infective inflammation diagnosis. Radiochemistry 55(5), 539 (2013).10.1134/S1066362213050159Search in Google Scholar

22. Taylor, M., Wallhaus, T. R., Degrado, T. R., Russell, D. C., Stanko, P., Nickles, R. J., Stone, C. K.: An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure. J. Nucl. Med. 42, 55 (2001).Search in Google Scholar PubMed

23. Budoff, M. J., Cohen, M. C., Garcia, M. J., Hodgson, J. M., Hundley, W. G., Lima, J. A., Manning, W. J., Pohost, G. M., Raggi, P. M., Rodgers, G. P., Rumberger, J. A., Taylor, A. J., Creager, M. A., Hirshfeld, J. W., Jr, Lorell, B. H., Merli, G., Rodgers, G. P., Tracy, C. M., Weitz, H. H.; American College of Cardiology Foundation; American Heart Association; American College of Physicians Task Force on Clinical Competence and Training; American Society of Echocardiography; American Society of Nuclear Cardiology; Society of Atherosclerosis Imaging; Society for Cardiovascular Angiography & Interventions.: ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J. Am. Coll. Cardiol. 46, 383 (2005).10.1016/j.jacc.2005.04.033Search in Google Scholar PubMed

24. Bateman, T., Dilsizian, V., Beanlands, R., DePuey, E. G., Heller, G., Wolinsky, D.: ASNC/SNMMI position statement on the clinical indications for myocardial perfusion PET. J. Nucl. Med. 57(10), 1654 (2016).10.2967/jnumed.116.180448Search in Google Scholar PubMed

25. Baggish, A. L., Boucher, C. A.: Radiopharmaceutical agents for myocardial perfusion imaging. Circulation 118(16), 1668 (2008).10.1161/CIRCULATIONAHA.108.778860Search in Google Scholar PubMed

26. Saraste, A., Nekolla, S. G., Schwaiger, M.: Cardiovascular molecular imaging: an overview. Cardiovasc. Res. 83, 643 (2009).10.1093/cvr/cvp209Search in Google Scholar PubMed

27. Tahara, N., Reinier Zandbergen, H., de Haas, H. J., Petrov, A., Pandurangi, R., Yamaki, T., Zhou, J., Imaizumi, T., Slart, R. H. J. A., Dyszlewski, M., Scarabelli, T., Kini, A., Reutelingsperger, C., Narula, N., Fuster, V., Narula, J.: Noninvasive molecular imaging of cell death in myocardial infarction using 111In-GSAO. Sci. Rep. 4, 6826 (2014).10.1038/srep06826Search in Google Scholar PubMed PubMed Central

28. Sanad, M. H., Farag, A.B., Dina, H. S.: Radioiodination and bioevaluation of rolipram as a tracer for brain imaging: in silico study, molecular modeling and gamma scintigraphy. J. Label Compd. Radiopharm. 61, 501 (2018).10.1002/jlcr.3614Search in Google Scholar PubMed

29. Sanad, M. H., Saleh, G. M., Marzook, F. A.: Radioiodination and biological evaluation of nizatidine as a new highly selective radiotracer for peptic ulcer disorder detection. J. Label Compd. Radiopharm. 60(13), 600 (2017).10.1002/jlcr.3541Search in Google Scholar PubMed

30. Siddiqui, N., Husain, A., Chaudhry, L., Alam, M., Mitra, M., Bhasin, P.: Pharmacological and pharmaceutical profile of valsartan: a review. J. Appl. Pharm. Sci. 1(4), 12 (2011).Search in Google Scholar

31. Vértes, A., Nagy, S., Klencsár, Z., Lovas, R. G., Rösch, F.: Handbook of Nuclear Chemistry (2011), 2nd ed. Springer, New York.10.1007/978-1-4419-0720-2Search in Google Scholar

32. Kuchar, M., Oliveira, M. C., Gano, L., Santos, I., Kniess, T.: Radioiodinated sunitinib as a potential radiotracer for imaging angiogenesis-radiosynthesis and first radiopharmacological evaluation of 5-[125I]Iodo-sunitinib. Bioorg. Med. Chem. Lett. 22(8), 2850 (2012).10.1016/j.bmcl.2012.02.068Search in Google Scholar PubMed

33. Rizvi, F. A., Bokhari, T. H., Roohi, S., Mushtaq, A.: Direct labeling ofdoxorubicin with technetium-99m: its optimization, characterization and quality control. J. Radioanal. Nucl. Chem. 12, 1662 (2012).10.1007/s10967-012-1662-9Search in Google Scholar

34. Faheem, A. R., Bokhari, T. H., Roohi, S., Mushtaq, A., Sohaib, M.: 99mTc-Daunorubicin a potential brain imaging and theranostic agent: synthesis, quality control, characterization, biodistribution and scintigraphy. J. Nucl. Med. Biol. 40, 148 (2013).10.1016/j.nucmedbio.2012.08.010Search in Google Scholar PubMed

35. Bokhari, T. H., Faheem, A. R., Samina, S. H., Mushtaq, A. M. K., Munwar, I.: Preparation, biodistribution and scintigraphic evaluation of 99mTc-lincomycin. Pak. J. Pharma. Sci. 28(6), 1965 (2015).Search in Google Scholar

36. Ravi, R. K., Devinder, K. D., Anshoo, M.: Synthesis, characterization and radiolabeling of bortezomib with 99mTc. Eur. J. Biophys. 3(3), 11 (2015).10.11648/j.ejb.s.2015030301.12Search in Google Scholar

37. Sanad, M. H., Sallam, Kh. M., Marzook, F. A., Abd-Elhaliem, S. M.: Radioiodination and biological evaluation of candesartan as a tracer for cardiovascular disorder detection J. Label Compd. Radiopharm. 59, 48 (2016).10.1002/jlcr.3435Search in Google Scholar PubMed

38. Sanad, M. H., Talaat, H. M., Ibrahim, I. T., Saleh, G. M., Abouzeid, L. A.: Radioiodinated celiprolol as a new highly selective radiotracer for β1-adrenoceptormyocardial perfusion imaging. Radiochim. Acta 106(9), 751 (2018).10.1515/ract-2017-2903Search in Google Scholar

39. Sanad, M. H., Ebtisam, A. M., Safaa, B. C.: Radioiodination of olmesartan medoxomil and biological evaluation of the product as a tracer for cardiac imaging. Radiochim. Acta 106(4), 329 (2018).10.1515/ract-2017-2830Search in Google Scholar

40. Sogbein, O. O., Pelletier-Galarneau, M., Schindler, T. H., Wei, L., Wells, R. G., Ruddy, T. D.: New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. BioMed Res. Int. 2014, 942960 (2014).10.1155/2014/942960Search in Google Scholar PubMed PubMed Central

41. Sanad, M. H.: Labeling of omeprazole with technetium-99m for diagnosis of stomach. Radiochemistry 55, 605 (2013).10.1134/S1066362213060076Search in Google Scholar

42. El-Shaboury, G., El-Kolaly, M. T., El-Wetery, A., El-Mohty, A., Raieh, M.: Proc. 6th Conf. Nucl. Sci. Appl.; Cairo, III, 181, 15–20 March, (1996).Search in Google Scholar

43. Bokhari, T. H., Muhammad, U. A., Samina, R., Saira H., Muhammad S., Faheem A. R.: Synthesis, characterization and biological evaluation of 99mTc-labeled mitomycin C. J. Radioanal. Nucl. Chem. 303(3), 1779 (2015).10.1007/s10967-014-3743-4Search in Google Scholar

44. Rashid, R., Saleha, T., Syed, A. R. N., Syed, J. H. G., Faheem, A. R., Muhammad, S. S. R.: 177Lu-5-fluorouracil a potential the ranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution and scintigraphy. J. Labelled Comp. Radiopharm. 59, 398 (2016).10.1002/jlcr.3423Search in Google Scholar PubMed

45. Faheem, A. R., Syed, A. R. N., Muhammad, M., Samina, R., Ameer, F. Z., Zulfiqar, A. K., Rashid, R.: Synthesis, quality control and biodistribution of technetium-99m triamcinolone acetonide (99mTc-TA) complex: an inflammation tracer agent. J. Chil. Chem. Soc. 62, 3345 (2017).10.4067/S0717-97072017000100008Search in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/ract-2018-2980).


Received: 2018-05-04
Accepted: 2018-07-10
Published Online: 2018-09-01
Published in Print: 2018-11-27

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 1.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ract-2018-2980/html?lang=en
Scroll to top button